WO1997005185A3 - Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatment agents - Google Patents

Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatment agents Download PDF

Info

Publication number
WO1997005185A3
WO1997005185A3 PCT/US1996/012285 US9612285W WO9705185A3 WO 1997005185 A3 WO1997005185 A3 WO 1997005185A3 US 9612285 W US9612285 W US 9612285W WO 9705185 A3 WO9705185 A3 WO 9705185A3
Authority
WO
WIPO (PCT)
Prior art keywords
controlled release
agents
tissue treatment
biodegradable hydrogels
drugs delivery
Prior art date
Application number
PCT/US1996/012285
Other languages
French (fr)
Other versions
WO1997005185B1 (en
WO1997005185A2 (en
Inventor
Chandrashekhar P Pathak
Shikha P Barman
C Michael Philbrook
Amarpreet Sawhney
Arthur J Coury
Luis Z Avila
Mark T Kieras
Original Assignee
Focal Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Focal Inc filed Critical Focal Inc
Priority to EP96926138A priority Critical patent/EP0842209B1/en
Priority to DE69636626T priority patent/DE69636626T2/en
Priority to JP9507762A priority patent/JPH11510837A/en
Publication of WO1997005185A2 publication Critical patent/WO1997005185A2/en
Publication of WO1997005185A3 publication Critical patent/WO1997005185A3/en
Publication of WO1997005185B1 publication Critical patent/WO1997005185B1/en
Priority to MXPA/A/1998/001706A priority patent/MXPA98001706A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0042—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/046—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/13—Burn treatment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S524/00—Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S524/916—Hydrogel compositions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S525/00—Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S525/941—Polymer mixture containing block copolymer is mixed or reacted with chemical treating agent

Abstract

Gel-forming macromers including at least four polymeric blocks, at least two of which are hydrophobic and at least one of which is hydrophilic, and including a crosslinkable group are provided. The macromers can be covalently crosslinked to form a gel on a tissue surface in vivo. The gels formed from the macromers have a combination of properties including thermosensitivity and lipophilicity, and are useful in a variety of medical applications including drug delivery and tissue coating.
PCT/US1996/012285 1995-07-28 1996-07-26 Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatment agents WO1997005185A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP96926138A EP0842209B1 (en) 1995-07-28 1996-07-26 Multiblock biodegradable hydrogels for use as controlled release agents for drugs and tissue treatment agents
DE69636626T DE69636626T2 (en) 1995-07-28 1996-07-26 BIODEGRADABLE MULTIBLOKHYDROGENES AND THEIR USE AS CARRIERS FOR CONTROLLED RELEASE PHARMACOLOGICALLY ACTIVE MATERIALS AND TISSUE CONTACT MATERIALS
JP9507762A JPH11510837A (en) 1995-07-28 1996-07-26 Multi-block biodegradable hydrogels for use as controlled release and tissue treatment agents for drug delivery
MXPA/A/1998/001706A MXPA98001706A (en) 1995-09-08 1998-03-03 Articles coated with dependable coatings capable of accepting organic pigment electrofotograf

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US172395P 1995-07-28 1995-07-28
US60/001,723 1995-07-28

Publications (3)

Publication Number Publication Date
WO1997005185A2 WO1997005185A2 (en) 1997-02-13
WO1997005185A3 true WO1997005185A3 (en) 1997-03-13
WO1997005185B1 WO1997005185B1 (en) 1997-05-15

Family

ID=21697509

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/012285 WO1997005185A2 (en) 1995-07-28 1996-07-26 Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatment agents

Country Status (7)

Country Link
US (5) US6201065B1 (en)
EP (1) EP0842209B1 (en)
JP (2) JPH11510837A (en)
AT (1) ATE342295T1 (en)
CA (1) CA2228118A1 (en)
DE (1) DE69636626T2 (en)
WO (1) WO1997005185A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8986730B2 (en) 2004-11-05 2015-03-24 Incept, Llc Methods for sealing a vascular puncture
CN109400816B (en) * 2018-08-24 2020-10-30 哈尔滨工业大学 Ultraviolet-curable color-changing gel resin and synthesis method thereof, and color changing and fading method of gel

Families Citing this family (282)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3011768B2 (en) * 1992-02-28 2000-02-21 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム Photopolymerizable biodegradable hydrophilic gels as tissue contacting materials and controlled release carriers
ATE342295T1 (en) * 1995-07-28 2006-11-15 Genzyme Corp BIODEGRADABLE MULTIBLOKHYDROGENS AND THEIR USE AS CARRIERS FOR CONTROLLED RELEASE PHARMACOLOGICALLY ACTIVE MATERIALS AND TISSUE CONTACT MATERIALS
US6696499B1 (en) * 1996-07-11 2004-02-24 Life Medical Sciences, Inc. Methods and compositions for reducing or eliminating post-surgical adhesion formation
US7009034B2 (en) * 1996-09-23 2006-03-07 Incept, Llc Biocompatible crosslinked polymers
US8003705B2 (en) * 1996-09-23 2011-08-23 Incept Llc Biocompatible hydrogels made with small molecule precursors
US20090324721A1 (en) * 1996-09-23 2009-12-31 Jack Kennedy Hydrogels Suitable For Use In Polyp Removal
WO1998012274A1 (en) 1996-09-23 1998-03-26 Chandrashekar Pathak Methods and devices for preparing protein concentrates
DE19640092A1 (en) * 1996-09-28 1998-04-16 Beiersdorf Ag Structures with lipid double membranes, in the lipophilic area of which longer-chain molecules are immersed or which are docked to such molecules through hydrophobic interactions
US6039757A (en) * 1997-03-12 2000-03-21 Cardiosynopsis, Inc. In situ formed fenestrated stent
WO1998041154A1 (en) 1997-03-20 1998-09-24 Focal, Inc. Biodegradable tissue retractor
US6211249B1 (en) * 1997-07-11 2001-04-03 Life Medical Sciences, Inc. Polyester polyether block copolymers
US5837752A (en) * 1997-07-17 1998-11-17 Massachusetts Institute Of Technology Semi-interpenetrating polymer networks
EP1512395A1 (en) * 1997-07-18 2005-03-09 Azopax Therapeutics LLC Biodegradable macromers for the controlled release of biologically active substances
CN1271277A (en) * 1997-07-18 2000-10-25 因菲米德有限公司 Biodegradable macromers fro the controlled release of biologically active substances
US5854382A (en) * 1997-08-18 1998-12-29 Meadox Medicals, Inc. Bioresorbable compositions for implantable prostheses
CA2316834C (en) 1998-01-07 2006-01-03 Shearwater Polymers, Inc. Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom
US6872384B1 (en) 1998-02-23 2005-03-29 Life Medical Sciences, Inc. Treatment of trauma
US6367929B1 (en) 1998-03-02 2002-04-09 Johnson & Johnson Vision Care, Inc. Hydrogel with internal wetting agent
WO1999059638A2 (en) * 1998-05-15 1999-11-25 Chiron Corporation Compositions and methods for the delivery of nucleic acid molecules
AU5180999A (en) * 1998-07-31 2000-02-21 First Water Limited Bioadhesive compositions comprising hydrophobic polymers
US6514534B1 (en) * 1998-08-14 2003-02-04 Incept Llc Methods for forming regional tissue adherent barriers and drug delivery systems
US6152943A (en) * 1998-08-14 2000-11-28 Incept Llc Methods and apparatus for intraluminal deposition of hydrogels
US7347850B2 (en) * 1998-08-14 2008-03-25 Incept Llc Adhesion barriers applicable by minimally invasive surgery and methods of use thereof
US6818018B1 (en) 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
US6632457B1 (en) * 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
WO2000033764A1 (en) 1998-12-04 2000-06-15 Pathak Chandrashekhar P Biocompatible crosslinked polymers
US20080114092A1 (en) * 1998-12-04 2008-05-15 Incept Llc Adhesion barriers applicable by minimally invasive surgery and methods of use thereof
EP1148895B1 (en) 1999-02-05 2004-11-17 The Regents of the University of California Thermo-reversible polymer for intralumenal implant
JP2002537069A (en) 1999-02-23 2002-11-05 ファーソン メジカル インク． How to treat damage
US6716445B2 (en) 1999-04-12 2004-04-06 Cornell Research Foundation, Inc. Hydrogel entrapping therapeutic agent and stent with coating comprising this
EP1168934B1 (en) * 1999-04-12 2008-02-13 Cornell Research Foundation, Inc. Hydrogel-forming system with hydrophobic and hydrophilic components
WO2000069942A1 (en) * 1999-05-19 2000-11-23 University Of Utah Research Foundation Stabilization and acoustic activation of polymeric micelles for drug delivery
US6579951B1 (en) * 1999-06-08 2003-06-17 Life Medical Sciences, Inc. Chain-extended or crosslinked polyethylene oxide/polypropylene oxide/polyethylene oxide block polymer with optional polyester blocks
ATE341345T1 (en) 1999-06-11 2006-10-15 Cytyc Corp LIQUID GEL FORMULATION FOR DETECTING MILK DUCTS IN THE BREAST PRIOR TO SURGICAL ABLATION OF THE BREAST TISSUE
RU2265615C2 (en) * 1999-09-01 2005-12-10 Родиа Шими Gel-like aqueous composition containing block copolymer wherein at least one water-soluble block and one hydrophobic block are available
WO2001044307A2 (en) * 1999-11-15 2001-06-21 Biocure, Inc. Degradable poly(vinyl alcohol) hydrogels
US6710126B1 (en) 1999-11-15 2004-03-23 Bio Cure, Inc. Degradable poly(vinyl alcohol) hydrogels
ATE427743T1 (en) 1999-11-15 2009-04-15 Biocure Inc POLYMERIC HOLLOW PARTICLES RESPONSIVE TO EXTRAORDINARY CONDITIONS
WO2001041735A2 (en) * 1999-12-07 2001-06-14 Amgen Inc. Thermosensitive biodegradable hydrogels based on low molecular weight pluronics
ATE310752T1 (en) * 2000-03-13 2005-12-15 Biocure Inc BIOMEDICAL ITEMS MADE OF HYDROGEL
DE60130544T2 (en) 2000-03-13 2008-06-26 Biocure, Inc. EMBOLIC COMPOSITIONS
US6652883B2 (en) 2000-03-13 2003-11-25 Biocure, Inc. Tissue bulking and coating compositions
AU2001252914A1 (en) * 2000-03-14 2001-09-24 Alnis Bioscience, Inc. Cryoprotective system
EP1272562A1 (en) * 2000-03-15 2003-01-08 CHENG, Yu-Ling Environment responsive gelling copolymer
US7160931B2 (en) 2000-03-15 2007-01-09 Yu-Ling Cheng Thermally reversible implant and filler
US7193007B2 (en) 2000-03-15 2007-03-20 Yu-Ling Cheng Environment responsive gelling copolymer
EP1289542B1 (en) * 2000-05-26 2008-07-16 Frohwitter, Bernhard Means for maintenance and/or correction of glucose concentration in blood
US20040091451A1 (en) * 2000-05-29 2004-05-13 Marie-Therese Charreyre Biocompatible polymer for fixing biological ligands
US8313504B2 (en) * 2000-09-18 2012-11-20 Cordis Corporation Foam matrix embolization device
US20040018228A1 (en) * 2000-11-06 2004-01-29 Afmedica, Inc. Compositions and methods for reducing scar tissue formation
FR2819416B1 (en) 2001-01-15 2004-12-17 Oreal TEHRMOGELIFYING FOAMING COMPOSITION AND FOAM OBTAINED
KR100496396B1 (en) * 2001-02-28 2005-06-20 다이니혼 잉키 가가쿠 고교 가부시키가이샤 Water absorbent material
US6949251B2 (en) * 2001-03-02 2005-09-27 Stryker Corporation Porous β-tricalcium phosphate granules for regeneration of bone tissue
US6529759B1 (en) * 2001-03-08 2003-03-04 Electrical Geodesics, Inc. Method for mapping internal body tissue
US20020192286A1 (en) * 2001-03-27 2002-12-19 Macromed, Incorporated Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof
US20040185101A1 (en) * 2001-03-27 2004-09-23 Macromed, Incorporated. Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof
US20040022853A1 (en) * 2001-04-26 2004-02-05 Control Delivery Systems, Inc. Polymer-based, sustained release drug delivery system
EP2283845A1 (en) * 2001-04-26 2011-02-16 pSivida Inc. Sustained release drug delivery system containing codrugs
ATE516759T1 (en) 2001-05-29 2011-08-15 Microvention Inc METHOD FOR PRODUCING EXPANDABLE FILAMENTOUS EMBOLIZATION DEVICES
US6939564B2 (en) * 2001-06-08 2005-09-06 Labopharm, Inc. Water-soluble stabilized self-assembled polyelectrolytes
US6730772B2 (en) 2001-06-22 2004-05-04 Venkatram P. Shastri Degradable polymers from derivatized ring-opened epoxides
KR100566911B1 (en) 2001-06-25 2006-04-03 주식회사 삼양사 Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug
WO2003006043A1 (en) * 2001-07-10 2003-01-23 Massachusetts Institute Of Technology Surfactant peptide nanostructures, and uses thereof
FR2829494B1 (en) * 2001-07-13 2005-10-28 Rhodia Chimie Sa AQUEOUS COMPOSITIONS COMPRISING A CHEMICAL MICRO-GEL ASSOCIATED WITH A POLYMER FOR PONDING, PREPARATION AND USE
US7226616B2 (en) * 2001-07-14 2007-06-05 Samyang Corporation Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug
US7572288B2 (en) 2001-07-20 2009-08-11 Microvention, Inc. Aneurysm treatment device and method of use
US8715312B2 (en) 2001-07-20 2014-05-06 Microvention, Inc. Aneurysm treatment device and method of use
US8252040B2 (en) 2001-07-20 2012-08-28 Microvention, Inc. Aneurysm treatment device and method of use
US20030082235A1 (en) * 2001-08-13 2003-05-01 Yissum Research Development Company Of The Hebrew University Of Jerusalem Novel reverse thermo-sensitive block copolymers
US20080063620A1 (en) * 2001-08-13 2008-03-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Novel reverse thermo-sensitive block copolymers
IN2014DN10834A (en) * 2001-09-17 2015-09-04 Psivida Inc
US7223282B1 (en) 2001-09-27 2007-05-29 Advanced Cardiovascular Systems, Inc. Remote activation of an implantable device
US6592899B2 (en) 2001-10-03 2003-07-15 Macromed Incorporated PLA/PLGA oligomers combined with block copolymers for enhancing solubility of a drug in water
US7842498B2 (en) 2001-11-08 2010-11-30 Bio-Rad Laboratories, Inc. Hydrophobic surface chip
WO2003054146A2 (en) * 2001-11-14 2003-07-03 Northwestern University Self-assembly and mineralization of peptide-amphiphile nanofibers
AU2002342455B8 (en) * 2001-11-15 2008-12-11 Biomatera Inc. Method for preparing gels
US7205337B2 (en) * 2001-12-21 2007-04-17 Isotis Orthobiologics, Inc. End-capped polymers and compositions containing such compounds
KR20040075901A (en) * 2001-12-21 2004-08-30 아이소티스 오르토바이올로직스, 인크. End-capped polyalkylene glycols and compositions containing such compounds
WO2003070805A1 (en) * 2002-02-15 2003-08-28 Nektar Therapeutics Al, Corporation Hydrolytically degradable alkylene oxide based polymers
WO2003070749A2 (en) * 2002-02-15 2003-08-28 Northwestern University Self-assembly of peptide-amphiphile nanofibers under physiological conditions
US20030229333A1 (en) * 2002-02-22 2003-12-11 Control Delivery Systems, Inc. Methods for treating otic disorders
US8298606B2 (en) 2002-03-08 2012-10-30 The Regents Of The University Of California Methods and compositions for stabilizing the myocardium
US7985601B2 (en) * 2002-03-08 2011-07-26 The Regents Of The University Of California Tunable, semi-interpenetrating polymer networks (sIPNS) for medicine and biotechnology
US20070026518A1 (en) * 2005-03-29 2007-02-01 The Regents Of The University Of California Controlling stem cell destiny with tunable matrices
US7018655B2 (en) 2002-03-18 2006-03-28 Labopharm, Inc. Amphiphilic diblock, triblock and star-block copolymers and their pharmaceutical compositions
US20030180348A1 (en) * 2002-03-22 2003-09-25 Levinson R. Saul Transcellular drug delivery system
WO2003080119A1 (en) * 2002-03-26 2003-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Responsive biomedical composites
US7005143B2 (en) 2002-04-12 2006-02-28 3M Innovative Properties Company Gel materials, medical articles, and methods
WO2003090662A2 (en) * 2002-04-25 2003-11-06 Rapidheal, Inc. Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
US20030203032A1 (en) * 2002-04-25 2003-10-30 Schultz Clyde L. Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
US20030204180A1 (en) * 2002-04-30 2003-10-30 Kimberly-Clark Worldwide, Inc. Temperature responsive delivery systems
US6923961B2 (en) * 2002-04-30 2005-08-02 Fziomed, Inc. Chemically activated carboxypolysaccharides and methods for use to inhibit adhesion formation and promote hemostasis
US8273366B2 (en) * 2002-06-05 2012-09-25 University Of Florida Research Foundation, Incorporated Ophthalmic drug delivery system
US7649023B2 (en) 2002-06-11 2010-01-19 Novartis Ag Biodegradable block copolymeric compositions for drug delivery
FR2840907B1 (en) * 2002-06-14 2005-11-25 Polymerexpert Sa ENHANCED THERMO-SENSITIVE POLYMER CAPABLE OF FORMING HIGH VISCOSIFICATION INJECTABLE THERMOREVERSIBLE GELS
US7160551B2 (en) * 2002-07-09 2007-01-09 The Board Of Trustees Of The University Of Illinois Injectable system for controlled drug delivery
CN101632843A (en) * 2002-08-20 2010-01-27 精密技术公司 Composition for the carrying and delivery of bone growth inducing material and methods for producing and applying the composition
US7534761B1 (en) 2002-08-21 2009-05-19 North Western University Charged peptide-amphiphile solutions and self-assembled peptide nanofiber networks formed therefrom
DE10238559A1 (en) * 2002-08-22 2004-03-04 Fresenius Medical Care Deutschland Gmbh Immobilising polymeric hydrogel on polymer surfaces, e.g. in dialysers, tubes or catheters, involves coating with hydrogel-forming polymer containing a flavine, flavone or flavonoid initiator and irradiating with UV-VIS light
US7862831B2 (en) * 2002-10-09 2011-01-04 Synthasome, Inc. Method and material for enhanced tissue-biomaterial integration
US8673333B2 (en) * 2002-09-25 2014-03-18 The Johns Hopkins University Cross-linked polymer matrices, and methods of making and using same
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
US20050069572A1 (en) * 2002-10-09 2005-03-31 Jennifer Elisseeff Multi-layered polymerizing hydrogels for tissue regeneration
US6800663B2 (en) * 2002-10-18 2004-10-05 Alkermes Controlled Therapeutics Inc. Ii, Crosslinked hydrogel copolymers
CA2505821C (en) * 2002-11-12 2012-08-21 The Polymer Technology Group Incorporated Control of polymer surface molecular architecture via amphipathic endgroups
US7554021B2 (en) 2002-11-12 2009-06-30 Northwestern University Composition and method for self-assembly and mineralization of peptide amphiphiles
AU2003298647A1 (en) 2002-11-14 2004-06-15 Claussen, Randal, C. Synthesis and self-assembly of abc triblock bola peptide
CN1849142A (en) 2002-11-15 2006-10-18 埃迪尼克斯(开曼)有限公司 2'-branched nucleosides and flaviviridae mutation
US20040185013A1 (en) * 2003-01-30 2004-09-23 Burgio Paul A. Dental whitening compositions and methods
US7223826B2 (en) * 2003-01-30 2007-05-29 3M Innovative Properties Company Amide-functional polymers, compositions, and methods
US20040151691A1 (en) * 2003-01-30 2004-08-05 Oxman Joel D. Hardenable thermally responsive compositions
CN1446833A (en) * 2003-02-08 2003-10-08 复旦大学 Warm sensitivity degradable micro gelatin and its preparation method
WO2004072104A2 (en) * 2003-02-11 2004-08-26 Northwestern University Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon
JP4909071B2 (en) * 2003-03-24 2012-04-04 プルーローメッド， インコーポレイテッド Temporary embolization using reverse thermosensitive polymers
US20050255144A1 (en) * 2003-04-09 2005-11-17 Directcontact Llc Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
US9216106B2 (en) 2003-04-09 2015-12-22 Directcontact Llc Device and method for the delivery of drugs for the treatment of posterior segment disease
US20050074497A1 (en) * 2003-04-09 2005-04-07 Schultz Clyde L. Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
FR2854071B1 (en) * 2003-04-25 2009-01-30 Ethypharm Sa METHOD FOR DISPERSION OF WATER-SOLUBLE OR HYDROPHILIC SUBSTANCES IN A SUPERCRITICAL PRESSURE FLUID
CA2523484A1 (en) * 2003-05-02 2004-11-11 Rimon Therapeutics Ltd. Thermally reversible implant
US20040249119A1 (en) * 2003-06-05 2004-12-09 Fox Martin Edward Novel mPEG propionaldehyde precursor
EP1648948B1 (en) 2003-07-18 2012-02-08 Agency for Science, Technology and Research Thermosensitive polymers for therapeutic use and methods of preparation
FR2862652B1 (en) * 2003-11-24 2006-04-28 Rescoll Soc PROCESS FOR OBTAINING THERMOREVERSIBLE GEL WITH THREE-DIMENSIONAL STRUCTURE CONTROLLED AND GEL OBTAINED
GB2408510B (en) * 2003-11-28 2008-05-14 Ind Tech Res Inst Thermosensitive biodegradable copolymer
CN102225964A (en) * 2003-12-05 2011-10-26 西北大学 Self-assembling peptide amphiphiles and related methods for growth factor delivery
WO2005056576A2 (en) * 2003-12-05 2005-06-23 Northwestern University Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof
WO2005055982A2 (en) * 2003-12-09 2005-06-23 University Of North Texas An aqueous dispersion of hydrogel nanoparticles with inverse thermoreversible gelation
GB0329654D0 (en) * 2003-12-23 2004-01-28 Smith & Nephew Tunable segmented polyacetal
US20050238678A1 (en) * 2004-03-05 2005-10-27 Janos Borbely Hydrogels from biopolymers
DE102004019504A1 (en) * 2004-04-22 2005-11-10 Celanese Ventures Gmbh New hydrogels based on polyvinyl alcohols and polyvinyl alcohol copolymers
US7758654B2 (en) 2004-05-20 2010-07-20 Kensey Nash Corporation Anti-adhesion device
WO2005115489A2 (en) * 2004-05-24 2005-12-08 Genzyme Corporation Adherent polymeric compositions
US20050287218A1 (en) * 2004-06-29 2005-12-29 Hassan Chaouk Biomaterial
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
CA2581896C (en) 2004-09-29 2015-11-10 Mount Sinai School Of Medicine Of New York University Fsh and fsh receptor modulator compositions and methods for inhibiting osteoclastic bone resorption and bone loss in osteoporosis
CN101098703B (en) 2004-11-05 2011-08-03 费城儿童医院 Biodegradable linkers for molecular therapies
WO2006057859A1 (en) * 2004-11-24 2006-06-01 Therakine Corporation An implant for intraocular drug delivery
US8128952B2 (en) * 2005-01-12 2012-03-06 Clemson University Research Foundation Ligand-mediated controlled drug delivery
MX2007008826A (en) * 2005-01-21 2007-11-15 Univ Northwestern Methods and compositions for encapsulation of cells.
AU2006213822B2 (en) * 2005-02-09 2011-05-26 Covidien Lp Synthetic sealants
WO2006089119A2 (en) * 2005-02-18 2006-08-24 Cartilix, Inc. Biological adhesive
KR20070108555A (en) * 2005-03-04 2007-11-12 노오쓰웨스턴 유니버시티 Angiogenic heparin binding peptide amphiphiles
US20060222596A1 (en) 2005-04-01 2006-10-05 Trivascular, Inc. Non-degradable, low swelling, water soluble radiopaque hydrogel polymer
US20060224095A1 (en) * 2005-04-05 2006-10-05 University Of New Hampshire Biocompatible polymeric vesicles self assembled from triblock copolymers
US9119901B2 (en) 2005-04-28 2015-09-01 Warsaw Orthopedic, Inc. Surface treatments for promoting selective tissue attachment to medical impants
US8414907B2 (en) 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing
TWI411528B (en) * 2005-05-12 2013-10-11 Clopay Plastic Prod Co Elastomeric films with brittle non-blocking skins
GB0515625D0 (en) * 2005-07-29 2005-09-07 Univ Manchester Hydrogel particle
WO2007016622A2 (en) * 2005-08-02 2007-02-08 Wright Medical Technolody, Inc. Gel composition for inhibiting cellular adhesion
US20070036842A1 (en) * 2005-08-15 2007-02-15 Concordia Manufacturing Llc Non-woven scaffold for tissue engineering
US7691946B2 (en) * 2005-09-30 2010-04-06 The United States Of America As Represented By The Secretary Of Agriculture Soy-based thermosensitive hydrogels for controlled release systems
US20070110788A1 (en) * 2005-11-14 2007-05-17 Hissong James B Injectable formulation capable of forming a drug-releasing device
US7432069B2 (en) * 2005-12-05 2008-10-07 Sontra Medical Corporation Biocompatible chemically crosslinked hydrogels for glucose sensing
US20070149641A1 (en) * 2005-12-28 2007-06-28 Goupil Dennis W Injectable bone cement
US20090196844A1 (en) * 2006-02-01 2009-08-06 Samyang Corporation Composition for inhibiting adhesion
US8795709B2 (en) * 2006-03-29 2014-08-05 Incept Llc Superabsorbent, freeze dried hydrogels for medical applications
US8747870B2 (en) 2006-04-20 2014-06-10 University Of Utah Research Foundation Polymeric compositions and methods of making and using thereof
AU2007240613B2 (en) * 2006-04-20 2013-11-28 University Of Utah Research Foundation Polymeric compositions and methods of making and using thereof
CA2650473C (en) * 2006-04-24 2013-06-18 Incept, Llc Protein crosslinkers, crosslinking methods and applications thereof
WO2007127785A2 (en) * 2006-04-25 2007-11-08 William Marsh Rice University Novel injectable macromonomers for the fabrication of hydrogels
US7872068B2 (en) * 2006-05-30 2011-01-18 Incept Llc Materials formable in situ within a medical device
US8273933B2 (en) * 2006-06-14 2012-09-25 Hewlett-Packard Development Company, L.P. Functionalized latex polymer and method of forming the same
KR101443926B1 (en) 2006-06-15 2014-10-02 마이크로벤션, 인코포레이티드 Embolization device constructed from expansible polymer
KR100773029B1 (en) * 2006-06-16 2007-11-05 이화여자대학교 산학협력단 Water soluble micelle-forming and biodegradable cyclotriphosphazene-paclitaxol conjugate anticancer agent and the preparation method thereof
CA2656179A1 (en) * 2006-06-21 2007-12-27 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for joining non-conjoined lumens
US8608760B2 (en) * 2006-06-21 2013-12-17 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for joining non-conjoined lumens
US8197499B2 (en) * 2006-06-21 2012-06-12 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for joining non-conjoined lumens
US8974542B2 (en) 2006-06-27 2015-03-10 University of Pittsburgh—of the Commonwealth System of Higher Education Biodegradable elastomeric patch for treating cardiac or cardiovascular conditions
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
EP2037938A2 (en) * 2006-07-12 2009-03-25 Controlled Therapeutics (Scotland) Ltd. Drug delivery polymer with hydrochloride salt of clindamycin
US7846361B2 (en) 2006-07-20 2010-12-07 Orbusneich Medical, Inc. Bioabsorbable polymeric composition for a medical device
WO2008033497A1 (en) * 2006-09-14 2008-03-20 The Research Foundation Of State University Of New York Nanostructured smart gel for time release drug delivery
AU2007298674A1 (en) * 2006-09-22 2008-03-27 Labopharm (Barbados) Limited Compositions and methods for pH targeted drug delivery
JP5277599B2 (en) * 2006-09-29 2013-08-28 日油株式会社 Method for producing biodegradable polyoxyalkylene derivative
US8889791B2 (en) * 2006-10-10 2014-11-18 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Thermoresponsive, biodegradable, elastomeric material
GB0620685D0 (en) * 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
CN101631513B (en) 2006-10-20 2013-06-05 奥巴斯尼茨医学公司 Bioabsorbable polymeric composition and medical device
US7959942B2 (en) 2006-10-20 2011-06-14 Orbusneich Medical, Inc. Bioabsorbable medical device with coating
EP1917971A1 (en) 2006-10-27 2008-05-07 Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) Substained release formulations comprising very low molecular weight polymers
US20080102123A1 (en) * 2006-10-27 2008-05-01 Schachter Deborah M Self-gelling tunable drug delivery system
CA2669673A1 (en) * 2006-11-14 2008-05-22 The Trustees Of The University Of Pennsylvania Efficient nuclear delivery of antisense oligonucleotides or sirna in vitro and vivo by nano-tranforming polymersomes
CA2677532A1 (en) * 2007-02-06 2008-08-14 Incept, Llc Polymerization with precipitation of proteins for elution in physiological solution
CA2678873C (en) 2007-02-19 2016-10-25 Plurogen Therapeutics, Inc. Compositions for treating biofilms and methods for using same
US20090227981A1 (en) * 2007-03-05 2009-09-10 Bennett Steven L Low-Swelling Biocompatible Hydrogels
US20090227689A1 (en) * 2007-03-05 2009-09-10 Bennett Steven L Low-Swelling Biocompatible Hydrogels
WO2008112565A2 (en) * 2007-03-09 2008-09-18 Anthony Manganaro Method and composition for treating cancer
US8076295B2 (en) * 2007-04-17 2011-12-13 Nanotope, Inc. Peptide amphiphiles having improved solubility and methods of using same
KR100838809B1 (en) * 2007-05-03 2008-06-17 성균관대학교산학협력단 Temperature and ph-sensitive block copolymer having excellent gel strength and method of making the same and injectable hydrogles using thereof
US8133553B2 (en) 2007-06-18 2012-03-13 Zimmer, Inc. Process for forming a ceramic layer
US8309521B2 (en) 2007-06-19 2012-11-13 Zimmer, Inc. Spacer with a coating thereon for use with an implant device
EP2162101B1 (en) * 2007-06-25 2019-02-20 MicroVention, Inc. Self-expanding prosthesis
US9125807B2 (en) 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
US8480651B2 (en) * 2007-08-02 2013-07-09 Covidien Lp Cannula system
NZ582948A (en) * 2007-08-02 2012-04-27 Basf Se Polymer networks comprising active ingredients, process for their production, and their use
US8067028B2 (en) * 2007-08-13 2011-11-29 Confluent Surgical Inc. Drug delivery device
US8608049B2 (en) 2007-10-10 2013-12-17 Zimmer, Inc. Method for bonding a tantalum structure to a cobalt-alloy substrate
US8299316B2 (en) 2007-12-18 2012-10-30 Ethicon, Inc. Hemostatic device
US8629314B2 (en) * 2007-12-18 2014-01-14 Ethicon, Inc. Surgical barriers having adhesion inhibiting properties
EP2224968A2 (en) * 2007-12-20 2010-09-08 Tautona Group, L.P. Compositions and methods for joining non-conjoined lumens
WO2009086208A2 (en) 2007-12-21 2009-07-09 Microvention, Inc. Hydrogel filaments for biomedical uses
US8486528B2 (en) * 2008-01-22 2013-07-16 Gwangju Institute Of Science And Technology Temperature-sensitive nano-carriers
US20090258070A1 (en) 2008-04-15 2009-10-15 John Burnier Topical LFA-1 antagonists for use in localized treatment of immune related disorders
WO2009132050A2 (en) 2008-04-21 2009-10-29 Otonomy, Inc. Auris formulations for treating otic diseases and conditions
US8263704B2 (en) * 2008-04-23 2012-09-11 Tyco Healthcare Group Lp Bioabsorbable surgical composition
US8030297B2 (en) 2008-05-14 2011-10-04 Otonomy, Inc. Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders
WO2010011466A2 (en) 2008-06-27 2010-01-28 Otonomy, Inc. Controlled-release cns modulating compositions and methods for the treatment of otic disorders
US8784870B2 (en) * 2008-07-21 2014-07-22 Otonomy, Inc. Controlled release compositions for modulating free-radical induced damage and methods of use thereof
CA2731766C (en) * 2008-07-21 2014-01-28 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
US8496957B2 (en) 2008-07-21 2013-07-30 Otonomy, Inc Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
WO2010053993A1 (en) 2008-11-04 2010-05-14 The Trustees Of Columbia University In The City Of New York Heterobifunctional polymers and methods for layer-by-layer construction of multilayer films
US8563037B2 (en) * 2009-02-06 2013-10-22 Tautona Group, L.P. Compositions and methods for joining non-conjoined lumens
EP2396070A4 (en) 2009-02-12 2012-09-19 Incept Llc Drug delivery through hydrogel plugs
KR20120012811A (en) * 2009-04-13 2012-02-10 노오쓰웨스턴 유니버시티 Novel peptide-based scaffolds for cartilage regeneration and methods for their use
US10639396B2 (en) 2015-06-11 2020-05-05 Microvention, Inc. Polymers
CA2760704C (en) 2009-05-04 2017-10-03 Incept, Llc Biomaterials for track and puncture closure
CA2762770C (en) 2009-05-19 2017-09-05 Plurogen Therapeutics, Inc. Surface active agent compositions and methods for enhancing oxygenation, reducing bacteria and improving wound healing
US20090298953A1 (en) * 2009-07-09 2009-12-03 Iran Polymer And Petrochemical Institute Drug delivery system and method of making the same
EP2480166B1 (en) 2009-09-24 2017-11-29 Microvention, Inc. Injectable hydrogel filaments for biomedical uses
US20110077216A1 (en) * 2009-09-30 2011-03-31 Massachusetts Institute Of Technology Compositions and methods for the treatment of atherosclerosis and other related diseases
WO2011043980A1 (en) 2009-10-07 2011-04-14 Sanford Burnham Medical Research Institute Methods and compositions related to clot-binding lipid compounds
BR112012009287A2 (en) * 2009-10-26 2017-06-06 Microvention Inc embolization device made of expandable polymer
JP2013509963A (en) 2009-11-09 2013-03-21 スポットライト テクノロジー パートナーズ エルエルシー Fragmented hydrogel
CN102695500A (en) 2009-11-09 2012-09-26 聚光灯技术合伙有限责任公司 Polysaccharide based hydrogels
EP2507310B1 (en) 2009-12-01 2017-09-06 Bridgestone Corporation Modified rubber compositions and methods of preparation
JP5820815B2 (en) 2009-12-15 2015-11-24 インセプト・リミテッド・ライアビリティ・カンパニーＩｎｃｅｐｔ，Ｌｌｃ Implants and biodegradable fiducial markers
KR101812820B1 (en) * 2010-01-08 2017-12-27 웨이크 포리스트 유니버시티 헬스 사이언시즈 Delivery system
US8835395B2 (en) 2010-03-10 2014-09-16 Kansas State University Research Foundation Protein peptide hydrogels
US20110223156A1 (en) * 2010-03-11 2011-09-15 Raibekas Andrei A Reversible gel protein formulation
US8551531B2 (en) 2010-04-12 2013-10-08 The Curators Of The University Of Missouri Pentablock polymers
CA3048850A1 (en) 2010-05-11 2011-11-17 Howmedica Osteonics Corp. Organophosphorous, multivalent metal compounds, & polymer adhesive interpenetrating network compositions & methods
US9232805B2 (en) 2010-06-29 2016-01-12 Biocure, Inc. In-situ forming hydrogel wound dressings containing antimicrobial agents
WO2012024390A2 (en) 2010-08-17 2012-02-23 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Biohybrid composite scaffold
US8961501B2 (en) 2010-09-17 2015-02-24 Incept, Llc Method for applying flowable hydrogels to a cornea
US8911712B2 (en) * 2010-10-04 2014-12-16 Church & Dwight, Co., Inc. Multi-purposed dentifrice
WO2012122105A1 (en) 2011-03-07 2012-09-13 Wake Forest University Health Sciences Delivery system
US9006345B2 (en) 2011-03-25 2015-04-14 The Trustees Of Columbia University In The City Of New York Heterotrifunctional molecules and methods for the synthesis of dendrimeric materials
CA2829791A1 (en) 2011-03-28 2012-10-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Sustained-release injectable formulation
WO2012145431A2 (en) 2011-04-18 2012-10-26 Microvention, Inc. Embolic devices
ES2667894T3 (en) 2011-04-21 2018-05-14 The Regents Of The University Of California Functionalized magnetic nanoparticles and their use in the imaging of amyloid deposits and neurofibrillar clews
JP2014522263A (en) 2011-05-11 2014-09-04 マイクロベンション インコーポレイテッド Device for occluding a lumen
US8765189B2 (en) 2011-05-13 2014-07-01 Howmedica Osteonic Corp. Organophosphorous and multivalent metal compound compositions and methods
US9943592B2 (en) 2011-05-26 2018-04-17 Kansas State University Research Foundation Vaccine adjuvants from self-assembling peptides
US10226417B2 (en) 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications
EP2766407B1 (en) * 2011-10-12 2018-06-27 The Curators Of The University Of Missouri Pentablock polymers
CA2852386C (en) * 2011-10-17 2019-05-21 Poly-Med, Inc. Absorbable in situ gel-forming system, method of making and use thereof
US8936784B2 (en) 2011-10-17 2015-01-20 Poly-Med, Inc. Absorbable in situ gel-forming system, method of making and use thereof
US20130101547A1 (en) 2011-10-19 2013-04-25 Allergan, Inc. Thermoresponsive compositions for dermatological use and methods thereof
US9089574B2 (en) 2011-11-30 2015-07-28 Emory University Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
WO2013158781A1 (en) 2012-04-18 2013-10-24 Microvention, Inc. Embolic devices
US9205175B2 (en) 2012-07-27 2015-12-08 Drexel University Thermosensitive and crosslinkable polymer composite for three-dimensional soft tissue scaffold printing
US9395468B2 (en) 2012-08-27 2016-07-19 Ocular Dynamics, Llc Contact lens with a hydrophilic layer
US8633296B1 (en) 2012-09-12 2014-01-21 International Business Machines Corporation Composite hydrogels for delivery of biologically active materials
US9707323B2 (en) 2012-11-12 2017-07-18 Warsaw Orthopedic, Inc. Devices and methods for inhibiting adhesion formation
US9474767B2 (en) 2012-11-12 2016-10-25 Warsaw Orthopedic, Inc. Compositions and methods for inhibiting bone growth
US9421221B2 (en) 2012-11-12 2016-08-23 Warsaw Orthopedic, Inc. Compositions and methods for inhibiting adhesion formation
DE102012223416A1 (en) 2012-12-17 2014-07-03 Polymaterials Ag Chain extended poloxamers, thermoreversible hydrogels formed therefrom with biological materials, and medical applications thereof
JP2016514030A (en) * 2013-03-14 2016-05-19 ジェンザイム・コーポレーション Thermosensitive bone growth composition
US9611353B2 (en) 2013-05-16 2017-04-04 The Curators Of The University Of Missouri Drug loading pentablock polymers
WO2015031393A1 (en) 2013-08-27 2015-03-05 Otonomy, Inc. Treatment of pediatric otic disorders
US9566296B2 (en) 2013-11-08 2017-02-14 Warsaw Orthopedic, Inc. Multi-layered anti-adhesion device
CA2930552C (en) 2013-11-15 2022-12-13 Ocular Dynamics, Llc Contact lens with a hydrophilic layer
US10472334B2 (en) 2014-03-14 2019-11-12 The University Of North Carolina At Chapel Hill Small molecules for inhibiting male fertility
US10124090B2 (en) 2014-04-03 2018-11-13 Terumo Corporation Embolic devices
CN106456836B (en) 2014-04-29 2019-12-06 微仙美国有限公司 Polymers comprising active agents
US10092663B2 (en) 2014-04-29 2018-10-09 Terumo Corporation Polymers
CN107206119B (en) 2014-12-09 2021-01-29 实体科学公司 Medical device coating with biocompatible layer
AU2016209327A1 (en) 2015-01-20 2017-08-10 Plurogen Therapeutics, Llc Compositions and methods of treating microbes
EP3269755A4 (en) * 2015-03-10 2018-11-21 The University of Tokyo Process for producing low-concentration gel using gel-precursor clusters, and gel obtained by said production process
JP2018515529A (en) 2015-05-12 2018-06-14 インセプト・リミテッド・ライアビリティ・カンパニーＩｎｃｅｐｔ，Ｌｌｃ Drug delivery from hydrogels
PE20181153A1 (en) * 2015-08-05 2018-07-17 Childrens Medical Center COMPOSITIONS WITH PRIZE POTENTIALS FOR THE SUPPLY OF DRUGS
US20170173209A1 (en) * 2015-12-18 2017-06-22 Rousseau Research, Inc. Wound closure compositions and method
US9868870B2 (en) 2016-03-16 2018-01-16 International Business Machines Corporation Hydrogel compositions for direct-write printing applications
US11040004B2 (en) 2016-09-16 2021-06-22 Otonomy, Inc. Otic gel formulations for treating otitis externa
US11911532B2 (en) 2017-03-29 2024-02-27 The Regents Of The University Of Colorado, A Body Corporate Reverse thermal gels and their use as vascular embolic repair agents
US10457772B2 (en) 2017-09-08 2019-10-29 International Business Machines Corporation Preparation of robust polythioaminal carriers
SE541313C2 (en) * 2017-10-13 2019-06-25 Amferia Ab Amphiphilic antimicrobial hydrogel
CA3107734A1 (en) * 2018-07-31 2020-02-06 The University Of Tokyo Polymer gel having sponge-like porous structure
EA202190672A1 (en) 2018-09-06 2021-07-01 Иссум Рисерч Дивелопмент Компани Оф Те Хибру Юниверсити Оф Джерусалем Лтд. SLOW RELEASE ANTIBIOTIC INJECTION
WO2020076578A1 (en) 2018-10-09 2020-04-16 University Of Rochester Treatment of vulvovaginal disorders
DE102020125546A1 (en) * 2020-09-30 2022-03-31 Leibniz-Institut Für Neue Materialien Gemeinnützige Gesellschaft Mit Beschränkter Haftung Novel hydrogels
WO2023220717A2 (en) * 2022-05-12 2023-11-16 The General Hospital Corporation Nanoparticle doped polyethylene glycol based gels and medical devices for drug delivery

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1595369A1 (en) * 1966-12-15 1970-04-09 Basf Ag Derivatives of block copolymers of ethylene oxide and 1,2-propylene oxide and process for their preparation
EP0108933A1 (en) * 1982-11-12 1984-05-23 American Cyanamid Company Poly(glycolic acid)/poly(oxyethylene)triblock copolymers and method of manufacturing the same
US4716203A (en) * 1986-09-05 1987-12-29 American Cyanamid Company Diblock and triblock copolymers
EP0552802A2 (en) * 1992-01-23 1993-07-28 Eastman Kodak Company Chemically fixed micelles comprising copolymer
US5410016A (en) * 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931337A (en) 1974-08-19 1976-01-06 Basf Wyandotte Corporation Multi-block polyacetal copolymer surfactants
US4189609A (en) 1974-08-19 1980-02-19 Basf Wyandotte Corporation Multi-block coupled polyoxyalkylene copolymer surfactants
DE2536121A1 (en) 1974-08-19 1976-03-04 Basf Wyandotte Corp SURFACE-ACTIVE BLOCK POLYOXYALKYLENE CO-POLYMERS
US3954886A (en) 1974-11-22 1976-05-04 Basf Wyandotte Corporation Alkali stable polyoxyethylene acetal surfactants
US3931148A (en) 1974-12-23 1976-01-06 Basf Wyandotte Corporation Hydroxyalkylamino glycosides and process of preparation
US4191820A (en) 1978-01-03 1980-03-04 Basf Wyandotte Corporation Process for preparing polyalkylene polyamine polyethers
US4178434A (en) 1978-01-03 1979-12-11 Basf Wyandotte Corporation Amine-coupled polyepichlorohydrin and polyamines derived therefrom
US4281199A (en) 1978-06-03 1981-07-28 Basf Wyandotte Corporation Polyalkylene polyamine ether derivatives of polyoxyalkylene compounds
US4261704A (en) 1979-06-22 1981-04-14 Basf Wyandotte Corporation Polyoxyalkylene polyamine detergent compositions
US4287078A (en) 1980-01-28 1981-09-01 Basf Wyandotte Corporation Surfactants derived from the reaction product of polyoxyalkylene polyols and polyglycidyl ethers and glycol-based antifreeze using same
US4314000A (en) 1980-11-03 1982-02-02 Basf Wyandotte Corporation Fiber lubricants yielding low residues upon oxidation
US4408084A (en) 1981-01-09 1983-10-04 Basf Wyandotte Corporation Non-ionic surfactants containing acetal groups
US4504418A (en) 1981-01-09 1985-03-12 Basf Wyandotte Corporation Non-ionic surface-active agents coupled with carbonates or carboxylic esters
US4519950A (en) 1981-01-16 1985-05-28 Basf Wyandotte Corporation Acetal group-containing non-ionic surfactants
ATE37983T1 (en) 1982-04-22 1988-11-15 Ici Plc DELAYED RELEASE AGENT.
US4757128A (en) 1986-08-01 1988-07-12 Massachusetts Institute Of Technology High molecular weight polyanhydride and preparation thereof
US4888176A (en) 1984-05-21 1989-12-19 Massachusetts Institute Of Technology Controlled drug delivery high molecular weight polyanhydrides
US4818542A (en) 1983-11-14 1989-04-04 The University Of Kentucky Research Foundation Porous microspheres for drug delivery and methods for making same
US4741337A (en) 1985-07-17 1988-05-03 Ethicon, Inc. Surgical fastener made from glycolide-rich polymer blends
US5160745A (en) 1986-05-16 1992-11-03 The University Of Kentucky Research Foundation Biodegradable microspheres as a carrier for macromolecules
IT1198449B (en) 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani ESTERS OF POLYVALENT ALCOHOLS OF HYALURONIC ACID
US4789724A (en) 1986-10-17 1988-12-06 Massachusetts Institute Of Technology Preparation of anhydride copolymers
IL82834A (en) 1987-06-09 1990-11-05 Yissum Res Dev Co Biodegradable polymeric materials based on polyether glycols,processes for the preparation thereof and surgical artiicles made therefrom
US4857311A (en) 1987-07-31 1989-08-15 Massachusetts Institute Of Technology Polyanhydrides with improved hydrolytic degradation properties
US5296627A (en) 1988-06-20 1994-03-22 Ppg Industries, Inc. Ethylenically unsaturated poly(alkyleneoxy) surfactants
US5328471A (en) 1990-02-26 1994-07-12 Endoluminal Therapeutics, Inc. Method and apparatus for treatment of focal disease in hollow tubular organs and other tissue lumens
US5213580A (en) 1988-08-24 1993-05-25 Endoluminal Therapeutics, Inc. Biodegradable polymeric endoluminal sealing process
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US4987744A (en) 1990-01-26 1991-01-29 Union Carbide Industrial Gases Technology Corporation Cryogenic distillation with unbalanced heat pump
US5078994A (en) 1990-04-12 1992-01-07 Eastman Kodak Company Microgel drug delivery system
CA2080224A1 (en) 1990-04-18 1991-10-19 Jindrich Kopecek Colonic-targeted oral drug-dosage forms based on crosslinked hydrogels containing azobonds and exhibiting ph-dependent swelling
US5219564A (en) 1990-07-06 1993-06-15 Enzon, Inc. Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
US5145518A (en) 1990-06-27 1992-09-08 Xerox Corporation Inks containing block copolymer micelles
US5512091A (en) 1990-08-13 1996-04-30 Steiner; Carol A. Associative polymer hydrogels
CA2101773A1 (en) 1991-01-31 1992-08-01 Toyoichi Tanaka Interpenetrating-polymer network phase-transition gels
GB9112267D0 (en) 1991-06-07 1991-07-24 Biocompatibles Ltd Polymeric coating
US5417983A (en) 1992-02-19 1995-05-23 Sagami Chemical Research Center Drug release controlling material responsive to changes in temperature
SE468771B (en) 1992-02-26 1993-03-15 Perstorp Ab DENDRITIC MACROMOLECYLE OF POLYESTER TYPE, PROCEDURES FOR PRODUCING THEREOF AND USING THEREOF
JP3011768B2 (en) 1992-02-28 2000-02-21 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム Photopolymerizable biodegradable hydrophilic gels as tissue contacting materials and controlled release carriers
US5573934A (en) * 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
KR940003548U (en) 1992-08-14 1994-02-21 김형술 Laundry dryer
ES2123135T3 (en) 1993-03-23 1999-01-01 Focal Inc APPARATUS AND METHOD FOR LOCAL APPLICATION OF POLYMERIC MATERIAL TO FABRIC.
TW272976B (en) 1993-08-06 1996-03-21 Ciba Geigy Ag
US5525657A (en) 1994-10-11 1996-06-11 Basf Corporation Latex composition employing specifically defined ethylene oxide/propylene oxide block copolymer surfactant and hydrophobic defoaming agent
ATE342295T1 (en) * 1995-07-28 2006-11-15 Genzyme Corp BIODEGRADABLE MULTIBLOKHYDROGENS AND THEIR USE AS CARRIERS FOR CONTROLLED RELEASE PHARMACOLOGICALLY ACTIVE MATERIALS AND TISSUE CONTACT MATERIALS
US5702717A (en) 1995-10-25 1997-12-30 Macromed, Inc. Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
JP4091080B2 (en) 2003-02-19 2008-05-28 富士通株式会社 Packet scheduling

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1595369A1 (en) * 1966-12-15 1970-04-09 Basf Ag Derivatives of block copolymers of ethylene oxide and 1,2-propylene oxide and process for their preparation
EP0108933A1 (en) * 1982-11-12 1984-05-23 American Cyanamid Company Poly(glycolic acid)/poly(oxyethylene)triblock copolymers and method of manufacturing the same
US4716203A (en) * 1986-09-05 1987-12-29 American Cyanamid Company Diblock and triblock copolymers
US5410016A (en) * 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
EP0552802A2 (en) * 1992-01-23 1993-07-28 Eastman Kodak Company Chemically fixed micelles comprising copolymer

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8986730B2 (en) 2004-11-05 2015-03-24 Incept, Llc Methods for sealing a vascular puncture
US9386969B2 (en) 2004-11-05 2016-07-12 Incept, Llc Methods for sealing a vascular puncture
CN109400816B (en) * 2018-08-24 2020-10-30 哈尔滨工业大学 Ultraviolet-curable color-changing gel resin and synthesis method thereof, and color changing and fading method of gel

Also Published As

Publication number Publication date
ATE342295T1 (en) 2006-11-15
US20050238722A1 (en) 2005-10-27
EP0842209B1 (en) 2006-10-11
MX9801706A (en) 1998-05-31
US6923986B2 (en) 2005-08-02
US6201065B1 (en) 2001-03-13
EP0842209A2 (en) 1998-05-20
CA2228118A1 (en) 1997-02-13
DE69636626D1 (en) 2006-11-23
US6639014B2 (en) 2003-10-28
US7250177B2 (en) 2007-07-31
US20020151650A1 (en) 2002-10-17
US6410645B1 (en) 2002-06-25
DE69636626T2 (en) 2007-08-30
JP2006097031A (en) 2006-04-13
JPH11510837A (en) 1999-09-21
US20040072961A1 (en) 2004-04-15
WO1997005185A2 (en) 1997-02-13

Similar Documents

Publication Publication Date Title
WO1997005185A3 (en) Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatment agents
AU5242701A (en) Wound gels
EP1105094B1 (en) Methods for forming regional tissue adherent barriers and drug delivery systems
CA2304976A1 (en) Delivery of poly(ethylene glycol)-conjugated molecules from degradable hydrogels
DE69523733T2 (en) THERMALLY GELING SUBSTANCES FOR THE DISPOSAL OF MEDICINAL PRODUCTS CONTAINING CELLULOSE ETHERS
DE69831802D1 (en) ACTIVE INGREDIENT RELIEF THROUGH THERAPEUTIC HYDROGEL
WO2006039276A3 (en) Lactam polymer derivatives
WO1996021470A3 (en) Compositions of nucleic acid and viscosity-increasing polymers for use in gene therapy
AU5056196A (en) Hydrogel-forming, self-solvating absorbable polyester copolymers and methods for use thereof
WO1997005185B1 (en) Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatment agents
WO2002039948A3 (en) Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants
US8821933B2 (en) Polymers and hydrogels
WO2002017880A3 (en) Nitric oxide-producing hydrogel materials
WO1995024430A3 (en) Block and graft copolymers and methods relating thereto
BR9711241B8 (en) process for making a polymeric composition to prevent or inhibit the formation of tissue adhesions or to inhibit bleeding
CA2165740A1 (en) Anti-adhesion films and compositions for medical use
EP1125577A3 (en) Liquid drug delivery compositions
CA2193805A1 (en) Devices and methods for application of intraluminal photopolymerized gels
AU2742401A (en) Methods and compositions for improved delivery devices
AU6628496A (en) Polyether block copolymer micellar compositions for targeting biological agents
AU8700898A (en) Bioresorbable compositions for implantable prostheses
AU6688900A (en) Biodegradable block copolymers with modifiable surface
Zaman et al. Hydrogels, their applications and polymers used for hydrogels: A review
WO2001015738A3 (en) Nitric oxide-producing hydrogel materials
Jindal et al. Hydrogels for localized drug delivery: A special emphasis on dermatologic applications

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2228118

Country of ref document: CA

Ref country code: CA

Ref document number: 2228118

Kind code of ref document: A

Format of ref document f/p: F

Ref country code: JP

Ref document number: 1997 507762

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1996926138

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: PA/a/1998/001706

Country of ref document: MX

WWP Wipo information: published in national office

Ref document number: 1996926138

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1996926138

Country of ref document: EP